文献速递传染病防控与疫情报告免疫规划

植物生产的疫苗保护小鼠抵抗致死性西尼罗病毒感染且不增强寨卡或登革病毒感染性

A plant-produced vaccine protects mice against lethal West Nile virus infection without enhancing Zika or dengue virus infectivity.
PubMed 文献 · Vaccine · 2018-02-26

研究在烟草本塞姆氏叶片中表达纯化西尼罗病毒包膜蛋白域III(plant-DIII),免疫小鼠可诱导抗原特异性细胞与体液免疫,DIII特异性抗体具中和活性且中和滴度达到与多种黄病毒疫苗保护性免疫相关的阈值。被动转移抗plant-DIII小鼠血清对致死性西尼罗病毒攻击提供完全保护;plant-DIII诱导的抗体在表达Fcγ受体的细胞中不增强寨卡病毒和登革病毒感染,首次报告一种西尼罗病毒亚单位疫苗可诱导保护性免疫同时规避对寨卡和登革病毒感染增强性抗体的产生。

要点

  • plant-DIII免疫小鼠诱导抗原特异性细胞免疫和体液免疫,DIII特异性抗体具中和活性。
  • 被动给予抗plant-DIII小鼠血清对小鼠致死性西尼罗病毒感染提供完全保护。
  • plant-DIII诱导的抗体在表达Fcγ受体的细胞中不增强寨卡病毒和登革病毒感染。

核心结论

  • 本研究首次报告一种西尼罗病毒亚单位疫苗可诱导保护性免疫,同时规避诱导对寨卡病毒和登革病毒感染具有增强活性的抗体。

研究设计与样本

  • 研究为小鼠体内实验,评估植物表达的西尼罗病毒包膜蛋白域III(plant-DIII)对西尼罗病毒感染的保护性免疫,并检测其是否增强后续寨卡病毒和登革病毒感染风险。

主要发现

  • plant-DIII免疫小鼠诱导抗原特异性细胞免疫应答以及体液应答。
  • DIII特异性抗体具中和活性,其中和滴度达到与多种黄病毒疫苗保护性免疫相关的阈值。
  • 被动给予抗plant-DIII小鼠血清对小鼠致死性西尼罗病毒感染攻击提供完全保护。
  • plant-DIII诱导的抗体在表达Fcγ受体的细胞中不增强寨卡病毒和登革病毒感染。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

West Nile virus (WNV) has caused multiple global outbreaks with increased frequency of neuroinvasive disease in recent years. Despite many years of research, there are no licensed therapeutics or vaccines available for human use. One of the major impediments of vaccine development against WNV is the potential enhancement of infection by related flaviviruses in vaccinated subjects through the mechanism of antibody-dependent enhancement of infection (ADE). For instance, the recent finding of enhancement of Zika virus (ZIKV) infection by pre-exposure to WNV further complicates the development of WNV vaccines. Epidemics of WNV and the potential risk of ADE by current vaccine candidates demand the development of effective and safe vaccines. We have previously reported that the domain III (DIII) of the WNV envelope protein can be readily expressed in Nicotiana benthamiana leaves, purified to homogeneity, and promote antigen-specific antibody response in mice. Herein, we further investigated the in vivo potency of a plant-made DIII (plant-DIII) in providing protective immunity against WNV infection. Furthermore, we examined if vaccination with plant-DIII would enhance the risk of a subsequent infection by ZIKV and Dengue virus (DENV). Plant-DIII vaccination evoked antigen-specific cellular immune responses as well as humoral responses. DIII-specific antibodies were neutralizing and the neutralization titers met the threshold correlated with protective immunity by vaccines against multiple flaviviruses. Furthermore, passive administration of anti-plant DIII mouse serum provided full protection against a lethal challenge of WNV infection in mice. Notably, plant DIII-induced antibodies did not enhance ZIKV and DENV infection in Fc gamma receptor-expressing cells, addressing the concern of WNV vaccines in inducing cross-reactive antibodies and sensitizing subjects to subsequent infection by heterologous flavivirus. This study provides the first report of a WNV subunit vaccine that induces protective immunity, while circumventing induction of antibodies with enhancing activity for ZIKV and DENV infection.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Lai H, Paul AM, Sun H, et al. A plant-produced vaccine protects mice against lethal West Nile virus infection without enhancing Zika or dengue virus infectivity. Vaccine. 2018. PMID: 29490880. doi:10.1016/j.vaccine.2018.02.073

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。